cystamine has been researched along with Idiopathic Pulmonary Fibrosis in 1 studies
Idiopathic Pulmonary Fibrosis: A common interstitial lung disease of unknown etiology, usually occurring between 50-70 years of age. Clinically, it is characterized by an insidious onset of breathlessness with exertion and a nonproductive cough, leading to progressive DYSPNEA. Pathological features show scant interstitial inflammation, patchy collagen fibrosis, prominent fibroblast proliferation foci, and microscopic honeycomb change.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Philp, CJ | 1 |
| Siebeke, I | 1 |
| Clements, D | 1 |
| Miller, S | 1 |
| Habgood, A | 1 |
| John, AE | 1 |
| Navaratnam, V | 1 |
| Hubbard, RB | 1 |
| Jenkins, G | 1 |
| Johnson, SR | 1 |
1 other study available for cystamine and Idiopathic Pulmonary Fibrosis
| Article | Year |
|---|---|
Extracellular Matrix Cross-Linking Enhances Fibroblast Growth and Protects against Matrix Proteolysis in Lung Fibrosis.
Topics: Airway Remodeling; Amino Acid Oxidoreductases; Animals; Bleomycin; Cell Adhesion; Cell Proliferation | 2018 |